The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ANACOR PHARMACEUTICALS INC | COM | 032420101 | 82,687 | 1,067,892 | SH | SOLE | 1,067,892 | 0 | 0 | ||
CARA THERAPEUTICS INC | COM | 140755109 | 32,417 | 2,668,057 | SH | SOLE | 2,668,057 | 0 | 0 | ||
EVERYDAY HEALTH INC | COM | 300415106 | 52,494 | 4,107,522 | SH | SOLE | 4,107,522 | 0 | 0 | ||
INOTEK PHARMACEUTICALS CORP | COM | 45780V102 | 14,066 | 2,870,584 | SH | SOLE | 2,870,584 | 0 | 0 | ||
INTRALINKS HLDGS INC | COM | 46118H104 | 77,302 | 6,490,503 | SH | SOLE | 6,490,503 | 0 | 0 | ||
NEPHROGENEX INC | COM | 640667101 | 6,992 | 1,052,966 | SH | SOLE | 1,052,966 | 0 | 0 | ||
REACHLOCAL INC | COM | 75525F104 | 8,097 | 2,570,395 | SH | SOLE | 2,570,395 | 0 | 0 | ||
RUBICON PROJ INC | COM | 78112V102 | 11,944 | 798,381 | SH | SOLE | 798,381 | 0 | 0 |